Inhibikase Therapeutics Inc — Balance Sheet (NASDAQ:IKT) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Total assets 42.47 M24.94 M14.51 M98.6 M181.2 M Total liabilities 4.05 M3.9 M3.53 M3.73 M8.3 M Total equity 38.42 M21.04 M10.98 M94.87 M172.9 M Total liabilities & shareholders' equities 42.47 M24.94 M14.51 M98.6 M181.2 M Total debt 248.91 K—622 K110.52 K— Net debt -40.5 M—-12.63 M-97.44 M—

Haberler

H.C. Wainwright, Inhibikase hissesi için hedefini korudu

Inhibikase, Faz 3 PAH ilaç denemesine ilk hastayı kaydetti

BofA Securities, Inhibikase hissesi için Alım tavsiyesi ile analize başladı

BofA Securities initiates coverage on Inhibikase stock with Buy rating

Jefferies reiterates Buy rating on Inhibikase stock, citing faster FDA path

H.C. Wainwright, Inhibikase hissesi için Al tavsiyesi ile takibe başladı

H.C. Wainwright assumes coverage on Inhibikase stock with Buy rating

Monday’s Insider Activity: Top Executives Trade Shares at Tech Giants

Why Intuit Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Gap (NYSE:GAP), Elastic (NYSE:ESTC)

Inhibikase Therapeutics 100 milyon dolarlık halka arz fiyatlandırmasını açıkladı

Inhibikase Therapeutics prices $100 million public offering

Inhibikase Therapeutics hisseleri halka arz duyurusunun ardından düştü